Bruno Lucidi
Independent DirectorMr. Bruno Lucidi has been an Independent Director of Atea Pharmaceuticals, Inc. since September 2014. Mr. Lucidi has served as an independent consultant to biotechnology companies since July 2013. He served as Chief Executive Officer of AgenTus Therapeutics, Inc. from October 2017 to September 2019. Mr. Lucidi served as Chief Executive Officer at MiNK Therapeutics, Inc. Mr. Lucidi served Vice President at GSK and Johnson and Johnson. He was in charge of global franchises, and Head of Oncology and Virology at Bristol Myers Squibb Europe. Mr. Lucidi is a senior executive with experience in pharmaceutical and biotechnology companies where he gained a unique transversal knowledge from drug discovery to market and demonstrated his ability to shape and implement successful strategies. He has held senior positions at GlaxoSmithKline. He served as the Chief Executive Officer of Aprea AB until January 2015. Mr. Lucidi served as Chief Executive Officer of Karolinska Development AB (publ) since October 15, 2014 until January 2015. He served as Chief Executive Officer of Akinion Pharmaceuticals AB. Since September 8, 2014, Mr. Lucidi served as Chief Executive Officer of the Karolinska Development's wholly owned subsidiary KDev Oncology AB and Aprea. Mr. Lucidi served as the Chief Executive Officer and President of Idenix Pharmaceuticals Inc. (formerly Novirio Pharmaceuticals Inc). He served as Chairman of Pharmasset and a Member of the Supervisory Board of Viroclinics Biosciences BV. Mr. Lucidi was a Life Sciences Expert at Wallonia Trade and Foreign Investment Agency from January 2017 to June 2020. He was trained in Oncology at the Gustave Roussy Institute, Villejuif, France, in Marketing and Strategic Management of Companies at the Ecole Superieure de Commerce, Paris, France, and in Finance, Merger and Acquisitions at the Investment Banking Institute in New York.
Positions
- Company NameAtea Pharmaceuticals, Inc.Stock CodeAVIRPositionIndependent DirectorColleagues
- JSJean-Pierre SommadossiFounder, Chairman, CEO & President
- AJAndrea J. CorcoranCFO, Executive VP of Legal & Secretary
- JFJohn F. VavrickaChief Commercial Officer
- JMJanet M. J. HammondChief Development Officer
- MAMaria Arantxa HorgaChief Medical Officer
- FMFranklin M. BergerLead Independent Director
- PAPolly A. MurphyIndependent Director
- BGBarbara G. DuncanIndependent Director
